WAUKESHA, Wis., July 18, 2016 /PRNewswire/ -- Cardiac Science announced today that its Board of Directors has appointed Devdatt (Dev) Kurdikar as Chief Executive Officer. Prior to joining Cardiac Science, Kurdikar was General Manager of the Boston Scientific Men's Health business.
Cardiac Science, a portfolio company of Los Angeles-based Aurora Resurgence, is a global leader in the manufacturing and marketing of automated external defibrillators (AEDs) for the public access, education, police, and fire and rescue markets.
Sean Ozbolt, Chairman, Cardiac Science Board of Directors, said, "The Board is excited to announce Dev's appointment as CEO to lead Cardiac Science through the next phase of its growth. Dev is a highly accomplished healthcare executive with an outstanding track record of success, and his experience leading global operations for major medical device businesses will be a tremendous asset to Cardiac Science. We look forward to a long, productive partnership with Dev and the exceptionally strong leadership team at Cardiac Science."
Kurdikar added, "I am honored to be appointed CEO of this world-class organization, and I am excited about the opportunity to help lead the continued resurgence of Cardiac Science. For over 25 years, this company has played a critical role in saving victims of sudden cardiac arrest around the world, and we will continue to support this mission as we expand our product lines and global presence. Today, Cardiac Science is growing meaningfully and there is an extraordinary passion to win at every level of the organization, and I look forward to working with this impressive team to build on the company's success."
About Devdatt Kurdikar Devdatt (Dev) Kurdikar has more than 20 years of experience in the life sciences and healthcare industry. He spent the last three years as the General Manager of the Men's Health business of Boston Scientific and that business's predecessor at American Medical Systems (AMS). Prior to AMS, Dev spent 11 years at Baxter Corporation in various leadership positions across several functional areas of Baxter's businesses, including strategy and operations, product development, finance, and marketing. Dev holds an MBA from Washington University in St. Louis, a Ph.D. in Chemical Engineering from Purdue University, an M.S. in Chemical Engineering from Washington State University and a B.S. in Chemical Engineering from the University of Bombay.
About Cardiac Science Cardiac Science is a global leader in the development, manufacturing and marketing of automated external defibrillators (AEDs) and related parts, components and accessories. The Company also provides a comprehensive portfolio of training, maintenance, and support services for AED customers. Cardiac Science is headquartered in Waukesha, Wisconsin and has operations in North America, Europe and Asia, with an installed base of over 500,000 units in nearly 100 countries worldwide. For information, call 1.800.426.0337 or visit http://www.cardiacscience.com.
For media questions, contact Ric Kositzke at +1.262.953.7624.